Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
Slovenia
16815375.7
Filed on 2017-12-21
16815375.7
Filed on 2017-12-21
Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
Austria
16815375.7
Filed on 2017-12-21
16815375.7
Filed on 2017-12-21
Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
Czech Republic
16815375.7
Filed on 2017-12-21
16815375.7
Filed on 2017-12-21
Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
Slovakia
16815375.7
Filed on 2017-12-21
16815375.7
Filed on 2017-12-21
Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
Switzerland
16815375.7
Filed on 2017-12-21
16815375.7
Filed on 2017-12-21
Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
Greece
16815375.7
Filed on 2017-12-21
16815375.7
Filed on 2017-12-21
Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
Hungary
16815375.7
Filed on 2017-12-21
16815375.7
Filed on 2017-12-21
Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
Ireland
16815375.7
Filed on 2017-12-21
16815375.7
Filed on 2017-12-21
Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
European Patent
16 815375.7
Filed on 2017-12-21
16 815375.7
Filed on 2017-12-21